WilmerHale-Led Stealth Biotherapeutics Debuts With $78M IPO
Venture capital-backed Stealth BioTherapeutics Inc. made its debut on the market Friday, one day after picking up $78 million in an initial public offering priced at the low end of the...To view the full article, register now.
Already a subscriber? Click here to view full article